PHARMACY

FDA approves Aurobindo’s Micardis generic

BY David Salazar

DAYTON, N.J. — Aurobindo Pharma announced Friday that the Food and Drug Administration had approved its generic version of Boehringer Ingelheim’s Micardis (telmisartan) tablets. The company’s telmisartan will be available in 20-, 40- and 80-mg tablets and is indicated to treat hypertension. 

IMS Health reports that the drug had U.S. sales about about $92.2 million for the 12 months ending in July.  

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer